4.7 Article

Real-World Impact of the Accelerate PhenoTest BC Kit on Patients With Bloodstream Infections in the Improving Outcomes and Antimicrobial Stewardship Study: A Quasiexperimental Multicenter Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Clinical Impact of Accelerate Pheno Rapid Blood Culture Detection System in Bacteremic Patients

Ryan K. Dare et al.

Summary: The implementation of AXDX significantly improved patient outcomes, including reduced length of stay, increased frequency of achieving optimal therapy, faster time to optimal therapy, and shorter total days of antimicrobial therapy. The results indicate that AXDX can be integrated into healthcare systems with an active antimicrobial stewardship program without the need for real-time notification.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

Sameer S. Kadri et al.

Summary: Approximately one in five patients with bloodstream infections in US hospitals received discordant empirical antibiotic therapy, which was closely associated with increased odds of mortality. Early identification of bloodstream pathogens and resistance will probably improve population-level outcomes.

LANCET INFECTIOUS DISEASES (2021)

Article Microbiology

Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia

Faith Babowicz et al.

Summary: The study evaluated the impact of Accelerate Pheno and BacT/Alert Virtuo systems on outcomes in patients with sepsis and concurrent Gram-negative bacteremia. Post-implementation, there were significantly shorter times for Gram stain and susceptibility results, improvements in narrow-spectrum Gram-negative therapy initiation at 72 hours, 30-day inpatient mortality, and sepsis resolution. Overall, the implementation of these systems improved microbiology laboratory processes, antibiotic utilization processes, and clinical outcomes, supporting the use of rapid diagnostics in sepsis with Gram-negative bacteremia.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Infectious Diseases

Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit

Shawn H. MacVane et al.

Summary: Implementation of AXDX testing for patients with Gram-positive bacteraemia shortened the time to optimal therapy (TTOT) and reduced unnecessary antibiotic exposure due to faster antibiotic modifications.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Microbiology

Assessment of Rapid-Blood-Culture-Identification Result Interpretation and Antibiotic Prescribing Practices

Linsey M. Donner et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2017)

Letter Critical Care Medicine

Antimicrobial de-escalation in septic cancer patients: is it safe to back down?

Alla Paskovaty et al.

INTENSIVE CARE MEDICINE (2015)

Article Medicine, General & Internal

Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay

Abigail Fraser et al.

AMERICAN JOURNAL OF MEDICINE (2006)